Instituto de Investigación del Hospital de La Princesa-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2024

  1. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

    Experimental Dermatology, Vol. 33, Núm. 8

  2. Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice

    Journal of the European Academy of Dermatology and Venereology, Vol. 38, Núm. 9, pp. 1783-1790

2023

  1. DNA Methylation Description of Hippocampus, Cortex, Amygdala, and Blood of Drug-Resistant Temporal Lobe Epilepsy

    Molecular Neurobiology, Vol. 60, Núm. 4, pp. 2070-2085

  2. Neuronal and astrocytic tetraploidy is increased in drug-resistant epilepsy

    Neuropathology and Applied Neurobiology, Vol. 49, Núm. 1

2022

  1. CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis

    Journal of Personalized Medicine, Vol. 12, Núm. 9

  2. Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?

    Epilepsy research, Vol. 187, pp. 107029